France· FR:61412965
MILRINONE TILLOMED 1 mg/mL, solution injectable/pour perfusion
A milrinone product containing milrinone, registered in France by TILLOMED PHARMA (ALLEMAGNE). The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Milrinone is registered in 16 of 19 countries.
Countries holding a registration under ATC C01CE02 (milrinone), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Milrinone · ATC C01CE02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MILRINONE
- Manufacturer
- TILLOMED PHARMA (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- C01CE02
- ATC class
- Milrinone
- Defined daily dose
- 50 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095508037410 flacons en verre de 10 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for milrinone.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Milrinone · interactions on record
5 records
- 5 moderate
Most severe, free to view
- ProcarbazineL01XB01moderate
- AnagrelideL01XX35moderate
- OzanimodL04AA38moderate
- OzanimodL04AE02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Milrinone in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMilrinon Carinopharm 1 mg/ml oplossing voor injectie/infusieCarinopharm GmbH
- United StatesMilrinone LactateEugia US LLC
- United KingdomMilrinone 10mg/10ml concentrate for solution for infusion ampoulesStragen UK Ltd
- Japanミルリノン高田製薬
- GermanyCorotropSanofi-Aventis Deutschland Gmbh
- FinlandMilnifarmOrifarm Oy
- BelgiumCorotrope 1 mg/mlSanofi Belgium
- SwedenCorotrop 1 mg/ml Injektionsvätska, lösningSanofi AB
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Asicor, Milrinon Carino
- Belgium · Corotrope
- Bulgaria · Milrinon Makpharm
- Czechia · Asicord, Corotrop
- Germany · Corotrop, Milrinon Carinopharm
- Denmark · Milnocor, Milrinon Stragen
- Spain · Corotrope, Milrinone
- Finland · Milnocor, Milrinon Stragen
- United Kingdom (Northern Ireland) · Milrinone Carinopharm, Milrinone Macure Pharma Uk
- Greece · Corotrope
- Croatia · Milrinon Makpharm
- Hungary · Corotrope, Unacor
- Ireland · Milrinone Pinewood Laboratories
- Luxembourg · Corotrope
- Malta · Milrinone Tillomed
- Netherlands · Milrinon Carinopharm, Milrinon Devrimed
- Norway · Milnocor, Milrinon Stragen
- Poland · Asicor, Corotrope
- Portugal · Corotrope
- Romania · Milrinone Zentiva, Unacor
- Sweden · Corotrop, Milrinon Carinopharm
- Slovenia · Milrinon Makpharm
- Slovakia · Asicord, Corotrope Inj
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8f15de0f-cbc3-44f4-a22a-1f5cdfd7d45c GET /v1/drugs/8f15de0f-cbc3-44f4-a22a-1f5cdfd7d45c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61412965",
"date_amm": "2022-10-05",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MILRINONE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable ou pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about milrinone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.